Sevion Therapeutics Inc Share Price OTC Bulletin Board
Equities
US81834Q1040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.97M 247M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.11
x | P/E ratio 2024 * |
-0.12
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Sevion Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01/21/01 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01/20/01 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08/21/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01/14/01 |
Alan Walts
BRD | Director/Board Member | 64 | 01/21/01 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01/21/01 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-2.45% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |